RANBAXY

Japan High on Indian Drugs

Ranbaxy CEORanbaxy CEOBy Priya Nigam


Ranbaxy Laboratories CEO Malvinder Mohan Singh would now be taking someone else’s company to greater heights! No, I don’t mean he’s resigned as Ranbaxy’s CEO. In a deal that is quite shocking, the Singh family has sold its complete stake in India’s largest pharmaceutical company to Japan’s Daiichi Sankyo.


Before going into the details of the deal, let me

Why The Sale Of Ranbaxy Is A Good Thing

Aditya Rao

Global Pharma and Ranbaxy DealGlobal Pharma and Ranbaxy DealIt was by no means the easiest decision for Malvinder Singh, the CEO of Ranbaxy laboratories to sell his stake to a Japanese company. After all this was the company started by his family years ago and made into one of the biggest Pharma companies in the world.

But at the end of the day, it was probably the right thing to do. For quite some

Ranbaxy: Aggressive As Ever

By Priya Nigam 

Ranbaxy is being very aggressiveRanbaxy is being very aggressiveLess than a decade back, traveling home from a party in the wee hours of the morning was quite a lonely journey. Ours would be the only car on the road. Now it’s not unusual to see Maruti gypsies zooming past at breakneck speed. Young boys and girls working in “call centers” are headed home after having persuaded (under a pseudonym of Julia or Bob) folks living in the US to pay back their credit card dues. 

The Latest: Airtel and Vodafone Essar in trouble, Blue Dart buying Boeing, Ranbaxy Looks at Punjab

By Vipin Agnihotri

This week The India Street brings you exclusive news from telecom giants Airtel and Vodafone Essar, Blue Dart and Ranbaxy.

Syndicate content